医学
前列腺癌
谷氨酸羧肽酶Ⅱ
放射性配体
生活质量(医疗保健)
模态(人机交互)
肿瘤科
前列腺
治疗方式
癌症
内科学
受体
人工智能
护理部
计算机科学
作者
László Szidonya,Tara Barwick,Amarnath Challapalli,Mitesh Naik,Amy Eccles,Dennis Barbon,Nadine Mallak
出处
期刊:Radiographics
[Radiological Society of North America]
日期:2024-11-21
卷期号:44 (12)
摘要
Prostate-specific membrane antigen (PSMA) radioligand therapy is an evolving treatment modality for patients with metastatic prostate cancer, offering improved survival and quality of life through a targeted and personalized theranostic approach.
科研通智能强力驱动
Strongly Powered by AbleSci AI